Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research capabilities Joint venture will...

16% Increase in Quarter-over-Quarter Revenue; Quarterly Expense Reduction of 17% TORONTO, May 30, 2019 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a leading technology company...

This is a copy of the May 19th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, One of the big criticisms of the...

Exclusive Interview with CB2Insights Co-Founder and CEO Prad Sekar CB2 Insights (CSE: CBII) (OTC: CBIIF) is using data and proprietary technology to drive the integration of medical cannabis into...

CB2 Insights Expands Board with Teladoc Executive Marc Adelson, Appoints David Danziger as Chairman and Adopts Advance Notice Bylaw Leading Telemedicine Firm’s Deputy Chief Legal Officer Joins Board Increasing...

CB2 Insights Announces FY2018 Financial Results After Transformative Year CB2 Insights to Host Conference Call Wednesday, May 1 at 4pm Eastern TORONTO, April 30, 2019 (GLOBE NEWSWIRE) — CB2...

Acquisition further strengthens medical cannabis data company’s financial metrics and data asset; reaching more than 85,000 patient evaluations per year TORONTO, April 10, 2019 (GLOBE NEWSWIRE) — CB2 Insights (“CB2” or...

Accretive acquisition of Colorado-based clinic group bolsters Company’s US medical cannabis clinical roll-up strategy; adds 15,000 new patients TORONTO, April 04, 2019 (GLOBE NEWSWIRE) — CB2 Insights (“CB2” or the “Company”)...

First acquisition post-RTO to consolidate the US medical cannabis clinical market; increases revenues, patient count and jurisdictions served TORONTO, March 20, 2019 (GLOBE NEWSWIRE) — CB2 Insights (“CB2” or the “Company”)...

Globally-Recognized Machine Learning Expert Joins as Senior Advisor to Data Insights Division TORONTO, March 14, 2019 (GLOBE NEWSWIRE) — CB2 Insights (“CB2” or the “Company”) (CSE:CBII) a leading global...

TORONTO, March 13, 2019 (GLOBE NEWSWIRE) — CB2 Insights Inc. (“CB2” or the “Company”) (CSE:CBII), has completed the conversion of 100% of its outstanding Convertible Senior Secured Debentures entered...

TORONTO, March 06, 2019 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the...

CB2 Insights Completes Reverse Take-over Transaction, to List on Canadian Securities Exchange Under Symbol “CBII” Leading Data Company Focused on Medical Cannabis to Commence Trading on March 6 TORONTO,...